Tackling the global burden of lung disease through prevention and early diagnosis
Three of the top six causes of death worldwide are lung diseases: chronic obstructive pulmonary disease (COPD), lower respiratory tract infections, and lung cancer.
As well as killing 7·6 million people every year, lung disease also causes distressing symptoms and disability for many more. The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
Puedes leer el artículo completo aquí:https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00302-2/fulltext
Noticias relacionadas
Human senescent fibroblasts trigger fibrogenic reaction in the lungs of immunodeficient mice
A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as «Aging (Albany NY)» and «Aging-US» by Web of Science) Volume 15, Issue 14, entitled, «Human senescent fibroblasts trigger progressive lung fibrosis in mice.»
COPD and multimorbidity: recognising and addressing a syndemic occurrence
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.
Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
The role of the immune response in the pathogenesis of idiopathic pulmonary fibrosis (IPF) remains controversial.
Más artículos
Estudios
- Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- Alvar Agusti, Peter G. Gibson, Vanessa M. McDonald. Treatable Traits in Airway Disease: From Theory to Practice
- Mona Bafadhel, Rosa Faner, Camille Taillé, Richard E.K. Russell, Tobias Welte, Peter J. Barnes and Alvar Agustí. Inhaled corticosteroids for the treatment of COVID-19
- Alvar Agusti, Claus F Vogelmeier, David M G Halpin. Tackling the global burden of lung disease through prevention and early diagnosis (2022/09)
- Vincent Cottin et Al. Syndrome of Combined Pulmonary Fibrosis and Emphysema. An Official ATS/ERS/JRS/ALAT Research Statement.
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida mediante capturas en el documento enlazado en la parte pública del artículo en (https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00302-2/fulltext) : https://www.healthdata.org/sites/default/files/files/policy_report/2019/GBD_2017_Booklet.pdf
